The prevalence and contents of advance directives in patients with pacemakers

Dario Pasalic, Tanya H. Tajouri, Abigale L. Ottenberg, Paul Mueller

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background Little is known about the use of advance directives (ADs) in patients who have implantable cardiac pacemakers (PMs). Methods We conducted a retrospective review of the medical records of residents of Olmsted County, Minnesota, who underwent implantation of a cardiac PM at Mayo Clinic (Rochester, Minnesota) during 2006 and 2007, and determined the prevalence and contents of ADs in these patients. Results During the study period, 205 residents of Olmsted County (men, 53%) underwent PM implantation (mean age [standard deviation] at implantation, 77 [15] years). Overall, 120 patients (59%) had ADs. Of these, 63 ADs (53%) were executed more than 12 months before and 33 (28%) were executed after PM implantation. Many patients specifically mentioned life-prolonging treatments in their ADs: cardiopulmonary resuscitation, 76 (63%); mechanical ventilation, 56 (47%); and hemodialysis, 31 (26%). Pain control was mentioned in 79 ADs (66%) and comfort measures were mentioned in 42 ADs (35%). Furthermore, the AD of many patients contained a general statement about end-of-life care (e.g., no "heroic measures"). However, only one AD (1%) specifically addressed the end-of-life management of the PM. Conclusions More than half of the patients with PMs in our study had executed an AD, but only one patient specifically mentioned her PM in her AD. These results suggest that patients with PMs should be encouraged to execute ADs and specifically address end-of-life device management in their ADs. Doing so may prevent end-of-life ethical dilemmas related to PM management.

Original languageEnglish (US)
Pages (from-to)473-480
Number of pages8
JournalPACE - Pacing and Clinical Electrophysiology
Volume37
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Advance Directives
Terminal Care
Cardiopulmonary Resuscitation
Artificial Respiration
Medical Records
Renal Dialysis

Keywords

  • advance directives
  • end-of-life care
  • ethics
  • pacemakers

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

The prevalence and contents of advance directives in patients with pacemakers. / Pasalic, Dario; Tajouri, Tanya H.; Ottenberg, Abigale L.; Mueller, Paul.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 37, No. 4, 01.01.2014, p. 473-480.

Research output: Contribution to journalArticle

Pasalic, Dario ; Tajouri, Tanya H. ; Ottenberg, Abigale L. ; Mueller, Paul. / The prevalence and contents of advance directives in patients with pacemakers. In: PACE - Pacing and Clinical Electrophysiology. 2014 ; Vol. 37, No. 4. pp. 473-480.
@article{3f3b1f1742c3445daf19a4be161ad8fa,
title = "The prevalence and contents of advance directives in patients with pacemakers",
abstract = "Background Little is known about the use of advance directives (ADs) in patients who have implantable cardiac pacemakers (PMs). Methods We conducted a retrospective review of the medical records of residents of Olmsted County, Minnesota, who underwent implantation of a cardiac PM at Mayo Clinic (Rochester, Minnesota) during 2006 and 2007, and determined the prevalence and contents of ADs in these patients. Results During the study period, 205 residents of Olmsted County (men, 53{\%}) underwent PM implantation (mean age [standard deviation] at implantation, 77 [15] years). Overall, 120 patients (59{\%}) had ADs. Of these, 63 ADs (53{\%}) were executed more than 12 months before and 33 (28{\%}) were executed after PM implantation. Many patients specifically mentioned life-prolonging treatments in their ADs: cardiopulmonary resuscitation, 76 (63{\%}); mechanical ventilation, 56 (47{\%}); and hemodialysis, 31 (26{\%}). Pain control was mentioned in 79 ADs (66{\%}) and comfort measures were mentioned in 42 ADs (35{\%}). Furthermore, the AD of many patients contained a general statement about end-of-life care (e.g., no {"}heroic measures{"}). However, only one AD (1{\%}) specifically addressed the end-of-life management of the PM. Conclusions More than half of the patients with PMs in our study had executed an AD, but only one patient specifically mentioned her PM in her AD. These results suggest that patients with PMs should be encouraged to execute ADs and specifically address end-of-life device management in their ADs. Doing so may prevent end-of-life ethical dilemmas related to PM management.",
keywords = "advance directives, end-of-life care, ethics, pacemakers",
author = "Dario Pasalic and Tajouri, {Tanya H.} and Ottenberg, {Abigale L.} and Paul Mueller",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/pace.12287",
language = "English (US)",
volume = "37",
pages = "473--480",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The prevalence and contents of advance directives in patients with pacemakers

AU - Pasalic, Dario

AU - Tajouri, Tanya H.

AU - Ottenberg, Abigale L.

AU - Mueller, Paul

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background Little is known about the use of advance directives (ADs) in patients who have implantable cardiac pacemakers (PMs). Methods We conducted a retrospective review of the medical records of residents of Olmsted County, Minnesota, who underwent implantation of a cardiac PM at Mayo Clinic (Rochester, Minnesota) during 2006 and 2007, and determined the prevalence and contents of ADs in these patients. Results During the study period, 205 residents of Olmsted County (men, 53%) underwent PM implantation (mean age [standard deviation] at implantation, 77 [15] years). Overall, 120 patients (59%) had ADs. Of these, 63 ADs (53%) were executed more than 12 months before and 33 (28%) were executed after PM implantation. Many patients specifically mentioned life-prolonging treatments in their ADs: cardiopulmonary resuscitation, 76 (63%); mechanical ventilation, 56 (47%); and hemodialysis, 31 (26%). Pain control was mentioned in 79 ADs (66%) and comfort measures were mentioned in 42 ADs (35%). Furthermore, the AD of many patients contained a general statement about end-of-life care (e.g., no "heroic measures"). However, only one AD (1%) specifically addressed the end-of-life management of the PM. Conclusions More than half of the patients with PMs in our study had executed an AD, but only one patient specifically mentioned her PM in her AD. These results suggest that patients with PMs should be encouraged to execute ADs and specifically address end-of-life device management in their ADs. Doing so may prevent end-of-life ethical dilemmas related to PM management.

AB - Background Little is known about the use of advance directives (ADs) in patients who have implantable cardiac pacemakers (PMs). Methods We conducted a retrospective review of the medical records of residents of Olmsted County, Minnesota, who underwent implantation of a cardiac PM at Mayo Clinic (Rochester, Minnesota) during 2006 and 2007, and determined the prevalence and contents of ADs in these patients. Results During the study period, 205 residents of Olmsted County (men, 53%) underwent PM implantation (mean age [standard deviation] at implantation, 77 [15] years). Overall, 120 patients (59%) had ADs. Of these, 63 ADs (53%) were executed more than 12 months before and 33 (28%) were executed after PM implantation. Many patients specifically mentioned life-prolonging treatments in their ADs: cardiopulmonary resuscitation, 76 (63%); mechanical ventilation, 56 (47%); and hemodialysis, 31 (26%). Pain control was mentioned in 79 ADs (66%) and comfort measures were mentioned in 42 ADs (35%). Furthermore, the AD of many patients contained a general statement about end-of-life care (e.g., no "heroic measures"). However, only one AD (1%) specifically addressed the end-of-life management of the PM. Conclusions More than half of the patients with PMs in our study had executed an AD, but only one patient specifically mentioned her PM in her AD. These results suggest that patients with PMs should be encouraged to execute ADs and specifically address end-of-life device management in their ADs. Doing so may prevent end-of-life ethical dilemmas related to PM management.

KW - advance directives

KW - end-of-life care

KW - ethics

KW - pacemakers

UR - http://www.scopus.com/inward/record.url?scp=84898543825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898543825&partnerID=8YFLogxK

U2 - 10.1111/pace.12287

DO - 10.1111/pace.12287

M3 - Article

C2 - 24215172

AN - SCOPUS:84898543825

VL - 37

SP - 473

EP - 480

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 4

ER -